Key facts
- This page summarizes Christine Chambers's Form 4 filing for PETMED EXPRESS INC (PETS).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 20 Jun 2023, 14:00.
Christine Chambers - 15 Jun 2023 Form 4 Insider Report for PETMED EXPRESS INC (PETS)
- SEC form
- 4
- Accepted by SEC
- 20 Jun 2023, 14:00:28 UTC
- Prior SEC filing
- 12 Jun 2023
- Next SEC filing
- 07 Nov 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christine Chambers
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Christine Chambers filed Form 4 for PETMED EXPRESS INC (PETS) on 20 Jun 2023.
Change
- Previous filing in this sequence was filed on 12 Jun 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PETS
transaction
Common Stock -Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +11,750
- Change %
- Price
- $0.000000
- Shares after
- 11,750
- Date
- 15 Jun 2023
- Ownership
- Direct
- Footnotes
- F1
PETS
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 13,000
- Date
- 15 Jun 2023
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PETS
transaction
Derivative
Performance Share Units
Award
- Transaction value
- $0
- Shares
- +8,000
- Change %
- Price
- $0.000000
- Shares after
- 8,000
- Date
- 15 Jun 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,000
- Exercise price
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Restricted stock units ("RSUs") granted pursuant to the PetMed Express, Inc.'s (the "Company") 2022 Employee Equity Compensation Restricted Stock Plan, as amended and restated (the "Plan"). One-third of the RSUs vest on each of the first, second and third anniversaries of June 15, 2023. Each RSU represents a right to receive one share of the Company's Common Stock upon vesting.
Footnote F2
Performance Share Units ("PSUs") granted pursuant to the Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a three-year performance period ending on March 31, 2026.